{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.56 vs. cons $2.53",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.50B vs. cons $1.51B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AST revenue",
      "prediction": "MISS",
      "answer": "pred ~$295M vs. cons $300M",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2027 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$11.20 vs. cons $11.18 (FY2027)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Reported revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.5% vs. cons 7.4% (FY2027)",
      "confidence": "HIGH"
    },
    {
      "kpi": "AST constant-currency organic growth",
      "prediction": "BETTER",
      "answer": "guide ~7.5% vs. cons 7.0% (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBIT-margin expansion",
      "prediction": "BETTER",
      "answer": "guide ~50 bps vs. cons 45 bps (FY2027)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -3.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "An unchanged FY2027 EPS midpoint after a predicted Q1 beat implies remaining-year EPS of ~$8.64 versus consensus remaining-year EPS of ~$8.65, offering no out-period upside. The predicted AST miss also makes the 7%\u20138% full-year AST target increasingly dependent on second-half acceleration, likely pressuring revisions despite the headline EPS beat.",
  "day5_confidence": "MEDIUM"
}